FDA Panel OKs Use Of Anemia Drugs, Despite Study
By Elaine Meyer ( October 18, 2010, 7:03 PM EDT) -- A U.S. Food and Drug Administration panel said Monday that it was safe for kidney patients who do not require dialysis to continue use of erythropoiesis-stimulating agents made by Johnson & Johnson and Amgen Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.